Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Berrie

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 5, 2011
Separation and maintenance of primary T and B lymphocytesD Kinchington, E Berrie
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 11, 2005
Design and manufacture of monoclonal antibodies for radioimmunotherapyG Hale, E Berrie, P Bird
Letters in Applied Microbiology|March 23, 2011
Hydrogen peroxide vapour (HPV) inactivation of adenovirusE Berrie, L Andrews, S Yezli, et al.
Research in Veterinary Science|January 1, 1985
Transmission of a malignant catarrhal fever-like syndrome to sheep: preliminary experimentsD Buxton, H W Reid, J Finlayson, et al.
The Veterinary Record|June 16, 1984
Malignant catarrhal feverH W Reid, D Buxton, E Berrie, et al.
Cytotherapy|August 13, 2002
Manufacture and quality control of CAMPATH-1 antibodies for clinical trialsJ Phillips, A Drumm, P Harrison, et al.
Genitourinary Medicine|June 1, 1986
Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDSJ N Weber, A McCreaner, E Berrie, et al.
British Medical Journal (Clinical Research Ed.)|February 21, 1987
Isolation of human immunodeficiency virus from synovial fluid of a patient with reactive arthritisR H Withrington, P Cornes, J R Harris, et al.
Lancet (London, England)|May 24, 1986
Three-year prospective study of HTLV-III/LAV infection in homosexual menJ N Weber, J Wadsworth, L A Rogers, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 5, 2011
Separation and maintenance of primary T and B lymphocytesD Kinchington, E Berrie
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 11, 2005
Design and manufacture of monoclonal antibodies for radioimmunotherapyG Hale, E Berrie, P Bird
Letters in Applied Microbiology|March 23, 2011
Hydrogen peroxide vapour (HPV) inactivation of adenovirusE Berrie, L Andrews, S Yezli, et al.
Research in Veterinary Science|January 1, 1985
Transmission of a malignant catarrhal fever-like syndrome to sheep: preliminary experimentsD Buxton, H W Reid, J Finlayson, et al.
The Veterinary Record|June 16, 1984
Malignant catarrhal feverH W Reid, D Buxton, E Berrie, et al.
Cytotherapy|August 13, 2002
Manufacture and quality control of CAMPATH-1 antibodies for clinical trialsJ Phillips, A Drumm, P Harrison, et al.
Genitourinary Medicine|June 1, 1986
Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDSJ N Weber, A McCreaner, E Berrie, et al.
British Medical Journal (Clinical Research Ed.)|February 21, 1987
Isolation of human immunodeficiency virus from synovial fluid of a patient with reactive arthritisR H Withrington, P Cornes, J R Harris, et al.
Lancet (London, England)|May 24, 1986
Three-year prospective study of HTLV-III/LAV infection in homosexual menJ N Weber, J Wadsworth, L A Rogers, et al.
Pageof 1